Professional Documents
Culture Documents
Name of Students: __Montecalbo, Hanniel , Taladro, Debbie Mae G. , Yuson, Johanna Maye_ Section: __BSN 2 –
A10___
Concept: ___Maternal and Child Health Nursing__________________________
Name of Clinical Instructor: __Dr. Ronnell Dela Rosa_______
Patients Data:
Occupation: ___Teacher______
Name: ____Celeste E. Maraguinot_____
Nationality: __Filipino____________
Gender: ______Female______________
Religion: ____Roman Catholic__________
Birth Date: ____May 16, 1999__________
Source of Data: ______________________
Birth Place: ___ Cebu City ____________
Date & Time of Admission: _2/18/20 7:15am_
Age: ________21______________________
Attending Physician: __Dr. Seboa________
Address: ___Canduman, Mandaue City____________
Diagnosis: G1P0 PU 36 6/7 weeks AOG, LMP,
Educational Level: ________________________
Mild Preeclampsia
Marital Status: __Married____________
Brief History Upon Admission: 2 days PTA patient felt mild headache, dizzy and light headed, she did not check
her blood pressure. No medication taken, condition tolerated, duration only in minutes.
1-day PTA patient was at work (elementary teacher) when she suddenly felt light headed, dizzy, with headache,
now more intense, she took her blood pressure and it was 140/90. Patient went home and had rest.
3H PTA sought consult with a private doctor, BP:150/90 and was advised for admission.
O: awake, alert, pink palpebral conjunctiva, clear breath sounds, equal chest expansion, dynamic precordium, no
murmur, gravida linea nigra, no contractions, FH: 33 cm, FHT 128 BPM
During normal pregnancy, the villous cytotrophoblast invades into the inner third of the
myometrium, and spiral arteries lose their endothelium and most of their muscle fibers. These structural
modifications are associated with functional alterations, such that spiral arteries become low-resistance
vessels, and thus less sensitive, or even insensitive, to vasoconstrictive substances.
Pre-eclampsia has a complex pathophysiology, the primary cause being abnormal placentation.
Defective invasion of the spiral arteries by cytotrophoblast cells is observed during pre-eclampsia. Recent
studies have shown that cytotrophoblast invasion of the uterus is actually a unique differentiation pathway
in which the fetal cells adopt certain attributes of the maternal endothelium they normally replace. In pre-
eclampsia, this differentiation process goes awry. The abnormalities may be related to the nitric oxide
pathway, which contributes substantially to the control of vascular tone. Moreover, inhibition of maternal
synthesis of nitric oxide prevents embryo implantation. Increased uterine arterial resistance induces higher
sensitivity to vasoconstriction and thus chronic placental ischemia and oxidative stress. This chronic
placental ischemia causes fetal complications, including intrauterine growth retardation and intrauterine
death. In parallel, oxidative stress induces release into the maternal circulation of substances such as free
radicals, oxidized lipids, cytokines, and serum soluble vascular endothelial growth factor 1. These
abnormalities are responsible for endothelial dysfunction with vascular hyperpermeability, thrombophilia,
and hypertension, so as to compensate for the decreased flow in the uterine arteries due to peripheral
vasoconstriction.
Pre-eclampsia can be perceived as an impairment of the maternal immune system that prevents it
from recognizing the fetoplacental unit. Excessive production of immune cells causes secretion of tumor
necrosis factor alpha which induces apoptosis of the extravillous cytotrophoblast. The human leukocyte
antigen (HLA) system also appears to play a role in the defective invasion of the spiral arteries, in that
women with pre-eclampsia show reduced levels of HLA-G and HLA-E. During normal pregnancies, the
interaction between these cells and the trophoblast is due to secretion of vascular endothelial growth
factor and placental growth factor by natural killer cells. High levels of soluble fms-like tyrosine kinase 1
(sFlt-1), an antagonist of vascular endothelial growth factor and placental growth factor, have been found
in women with pre-eclampsia.
Followed by:
Parts of the organ and functions of each part
Definition of the disease:
Clinical Manifestation/Signs & Symptoms
Laboratory Test:
2/18/20 CBC WBC: 13.3 4.4 – 11.0 High, an infection may be present
NEU: 74.9 37.0-80.0 NORMAL
LYM: 13.4 10.0-50.0 NORMAL
MON: 10.6 0.0-12.0 NORMAL
EOS: 0.7 0.0-7.0 NORMAL
BAS: 0.4 0.0-2.5 NORMAL
RBC: 4.04 4.5 – 5.1 Low, indicate anemia
HGB: 12.4 12.3 – 15.3 NORMAL
HCT: 38.3 35.9 – 44.6 NORMAL
MCV: 95 80 – 96 NORMAL
MCH: 30.8 27.5 – 33.2 NORMAL
MCHC: 32.4 32.0 – 36.0 NORMAL
RDW: 12.1 11.6 – 14.8 NORMAL
PLT: 188 150 – 450 NORMAL
MPV: 7.4 6.0 – 11.0 NORMAL
Diagnostic Test:
Problem List
5
Ineffective tissue perfusion related to vasoconstriction of blood vessels
Drug Study
Drug name Classification Mechanism Indication Contraindication Adverse Nursing
of action reaction responsibilities
-Serious
Skin
Reactions
-
Hematologi
c Toxicity
Perioperativ Skin:
e maculopap
prophylaxis. ular and
erythemato
Gonorrhea us rash,
(urethral, urticaria,
endocervic pain,
al, rectal). induration,
sterile
abscesses,
temperatur
e elevation,
tissue
sloughingat
injection
site.
Other:
hypersensit
ivity
reactions
(serum
sickness,
anaphylaxis
).
Drug name Classification Mechanism Indication Contraindication Adverse Nursing
of action reaction responsibilities
Reference:
https://nurseslabs.com
/preterm-labor-nursing-
care-plans/
FDAR
Date Focus Time DAR
2/18/20 Receiving assessment 9: 40 PM D: Received patient awake, alert, pink palpebral conjunctiva,
clear breath
Hypertension 10:00 sounds, equal chest expansion, dynamic precordium, no
PM murmur, gravida
linea nigra, no contractions, FH: 33 cm, FHT: 128 bpm.
V/S: BP: 150/90, HR: 94, RR: 24, Temp.: 37.1, O2 Sat:
98%.
D: Patient felt mild headache, dizzy and light headed, she did
not check
her blood pressure. No medication taken, condition tolerated,
duration
only in minutes
A: Establish rapport with the patient. The patient's general
condition was
assessed. Check the patient's test results to see if there were
any
contributing variables. Both hands should be used to monitor
and record
blood pressure. During pain bouts, the patient was
encouraged to rest
and limit movement.
R: Patient is at ease and states that she is feeling much
better.
AMETHOD of discharge planning was developed and modified to provide a systematic method for
ensuring client’s needs during the termination phase of hospitalization. The AMETHOD represent areas the nurse
should consider before the client goes home. The Discharge plan follows the FDAR format. AMETHOD is placed
in the Implementation.
2/22/20 Discharges 10:20am D: With discharge order from attending physician Dr. Seboa
instructions
A: Activity: The client is assisted in attaining his or her
highest level of mobility possible before discharge.
Medication:
Cefuroxime (Altoxime) 500 mg 1 tab BID PO/6 days, works by
stopping the growth of bacteria.
Nausea, vomiting, diarrhea, strange taste in the
mouth, or stomach pain may occur as side effects.
Should be taken orally or by mouth.
Mefenamic Acid (Alfemen) 500 mg 1cap q 6o, used to relieve mild
to moderate pain. Side effect includes, diarrhea,
constipation, stomach pain, gas, heartburn, nausea,
vomiting, and dizziness. Taken orally.
Nifedipine (Adalat Gits) 30 mg/tab 1 tab OD P.O. x 1 week, works
by relaxing blood vessels so blood can flow more
easily. Side effect includes, constipation, nausea,
heartburn, flushing and dizziness. Taken orally.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148420/
https://www.rnpedia.com/nursing-notes/pharmacology-drug-study-
notes/nifedipine/#:~:text=WARNING%3A%20Monitor%20patient%20carefully%20(BP,or%20divide%20sustained%
2Drelease%20tablets.
https://www.cdc.gov/bloodpressure/pregnancy.htm
https://nurseslabs.com/pregnancy-induced-hypertension-nursing-care-
plans/#:~:text=Early%20recognition%20and%20prompt%20treatment,Decreased%20Cardiac%20Output
https://nurseslabs.com/ineffective-tissue-perfusion/
https://nurseslabs.com/pregnancy-induced-hypertension-nursing-care-
plans/#:~:text=Early%20recognition%20and%20prompt%20treatment,Decreased%20Cardiac%20Output
https://nurseslabs.com/preterm-labor-nursing-care-plans/
https://nurseslabs.com/labor-stages-labor-induced-nursing-care-plan/#a4
https://www.cdc.gov/bloodpressure/pregnancy.htm
https://www.rnpedia.com/nursing-notes/pharmacology-drug-study-
notes/nifedipine/#:~:text=WARNING%3A%20Monitor%20patient%20carefully%20(BP,or%20divide%20sustained%2Drelease%20tabl
ets.